Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-16

FDA Approved: POSFREA — Supplemental Application (Avyxa Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for POSFREA (palonosetron) from Avyxa Pharma, LLC. The approval updates the product labeling to reflect the approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POSFREA (PALONOSETRON)

Snippet

SUPPL AP for POSFREA (PALONOSETRON)